Insider · CIK 0001497166
Alexander K. Arrow
Files at PTIX (Protagenic Therapeutics, Inc.\new). First filing Oct 13, 2023, latest Oct 13, 2023.
In brief
Alexander K. Arrow files SEC Form 4 as CFO at PTIX (Protagenic Therapeutics, Inc.\new). Since Oct 13, 2023, Alexander K. Arrow has reported 1 open-market buy worth $6,480 and 0 open-market sells worth $0, the latest filed on Oct 13, 2023.
A track record needs three past buys with six months of prices behind them; Alexander K. Arrow has 1, so none is measured yet.
The newest scored trade: bought $6,480 of PTIX on Oct 12, 2023, filed Oct 13, 2023, scored 46 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PTIX: Protagenic Therapeutics, Inc.\new
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | PTIXbuy Protagenic Therapeutics, Inc.\new | $6,480 8,000 shares | +21% | 0% from low-72% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | PTIX Protagenic Therapeutics, Inc.\new | AGrant or award PTIX Common stock Optionsderivative | +100,000 | $1.74 | $174k | 100,000 | Mar 29, 2024 |
| Oct 12, 2023 | PTIX Protagenic Therapeutics, Inc.\new | POpen-market purchase PTIX Common Stock | +8,000 | $0.81 | $6,480 | 45,815 | Oct 13, 2023 |
Questions about Alexander K. Arrow
Answered from the filings on this page, as of the latest one.
Is Alexander K. Arrow buying or selling?
Not in the last 12 months. Alexander K. Arrow's latest open-market trade on SEC Form 4 was bought $6,480 of PTIX on Oct 12, 2023.
How did Alexander K. Arrow's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alexander K. Arrow has 1.
Where does Alexander K. Arrow file Form 4?
Alexander K. Arrow has filed Form 4 at PTIX (Protagenic Therapeutics, Inc.\new) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.